Protagonist Therapeutics, Inc. (PTGX)
96.76
+4.67
(+5.07%)
USD |
NASDAQ |
Mar 09, 16:00
95.00
-1.76
(-1.82%)
After-Hours: 18:00
Protagonist Therapeutics SG&A Expense (TTM) : 44.85M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Johnson & Johnson | 23.68B |
| ADMA Biologics, Inc. | 96.42M |
| Glaukos Corp. | 331.75M |
| Krystal Biotech, Inc. | 146.91M |
| Olema Pharmaceuticals, Inc. | 18.61M |